• 1
    Mathews R., Hall W., Carter A. Direct-to-consumer genetic testing for addiction susceptibility: a premature commercialisation of doubtful validity and value. Addiction; 2012; 107: 20692074.
  • 2
    Secretary's Advisory Committee on Genetic Testing. Enhancing the Oversight of Genetic Tests: Recommendations of the SACGT. Bethesda, MD: National Institutes of Health; 2000.
  • 3
    Secretary's Advisory Committee on Genetics, Health, and Society. U.S. System of Oversight of Genetic Testing: A Response to the Charge of the Secretary of Health and Human Services. Bethesda, MD: National Institutes of Health; 2008.
  • 4
    Javitt G. H., Hudson K. Federal neglect: regulation of genetic testing. Issues Sci Technol 2006; 22: 5866.
  • 5
    Lee S. S. J., Crawley L. Research 2.0: social networking and direct-to-consumer (DTC) genomics. Am J Bioeth 2009; 9: 3544.
  • 6
    McBride C. M., Wade C. H., Kaphingst K. A. Consumers’ view on direct-to-consumer genetic information. Annu Rev Genomics Hum Genet 2010; 11: 427446.
  • 7
    Bloss C. S., Schork N. J., Topol E. J. Effect of direct-to-consumer genomewide profiling to assess disease risk. N Engl J Med 2011; 364: 524534.
  • 8
    Bloss C. S., Darst B. F., Topol E. J., Schork N. J. Direct-to-consumer personalized genomic testing. Hum Mol Genet 2011; 20: R132141.
  • 9
    James K. M., Cowl C. T., Tilburt J. C., Sinicrope P. S., Robinson M. E., Frimannsdottir K. R. et al. Impact of direct-to-consumer predictive genomic testing on risk perception and worry among patients receiving routine care in a preventive health clinic. Mayo Clin Proc 2011; 86: 933940.
  • 10
    Shields A. E. Ethical concerns related to developing pharmacogenomic treatment strategies for addiction. Addict Sci Clin Pract 2011; 6: 3243.
  • 11
    Chen L. S., Baker T. B., Piper M. E., Breslau N., Cannon D. S., Doheny K. F. et al. Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success. Am J Psychiatry 2012; 169: 735742.
  • 12
    Dingel M. J., Karkazis K., Koenig B. A. Nicotine addiction: a ‘disease of the brain'? Social and ethical consequences. Soc Sci Q 2011; 92: 13631388.